Beta-blockers, particularly propranolol, reduce the physical symptoms of anxiety, racing heart, trembling, sweating, by blocking the effects of adrenaline on the body. They're used short-term for specific performance situations (public speaking, auditions, exams) and occasionally for the somatic component of generalized anxiety. They don't treat the underlying anxiety; they reduce the bodily experience of it.
For plain-language detail on any specific medication, including what to expect week by week, side effects, and how to come off it, see our sister publication PsychiatryRx.
Beta-blockers occupy an unusual place in anxiety treatment. They aren't anti-anxiety medications in the way SSRIs or benzodiazepines are. They're blood pressure medications, originally developed for cardiac conditions, that turn out to be effective at reducing the physical manifestations of acute anxiety. Knowing the distinction is the key to using them appropriately.
What beta-blockers do
Beta-blockers compete with adrenaline for binding at beta-adrenergic receptors throughout the body. The result: reduced heart rate, reduced force of contraction, reduced blood pressure, reduced peripheral signs of sympathetic activation (trembling, sweating, vocal tremor). They don't cross the blood-brain barrier substantially (especially the non-selective beta-blockers like propranolol used for anxiety), so they reduce the body's experience of anxiety without sedating the mind.
This is why propranolol works specifically well for performance anxiety, situations where the physical signs of activation (racing heart, shaky hands, voice quavering) are themselves the problem because they're visible to others. Take a small dose thirty to sixty minutes before the event, and the body stays relatively quiet while the mind remains alert and clear.
What they don't do
Beta-blockers don't address the worry, the rumination, or the cognitive component of anxiety. A patient with generalized anxiety disorder will continue to ruminate on propranolol. The thoughts aren't affected. Only the body's response to the thoughts is dampened.
This makes beta-blockers a poor first-line choice for generalized anxiety disorder, panic disorder, social anxiety disorder, OCD, or PTSD as standalone treatments. They're an adjunct, not a primary intervention.
Performance anxiety versus generalized anxiety
Beta-blockers occupy a specific clinical niche in anxiety. They aren't first-line for generalized anxiety disorder, panic disorder, or OCD. They don't address anxious cognition, the worry pattern, or the underlying anxious arousal that drives those conditions over time. SSRIs and behavioral treatment do.
What beta-blockers do address well is the peripheral autonomic component of performance anxiety: the racing heart, the shaking hands, the trembling voice that a person notices in a discrete high-stakes situation such as public speaking, a musical performance, or a presentation. Propranolol taken 30 to 60 minutes before the event blunts these peripheral symptoms without affecting cognition meaningfully. This is the use case for which beta-blockers have the most consistent evidence in anxiety.
A few clinical considerations:
Beta-blockers aren't appropriate in patients with asthma, COPD with bronchospastic features, certain bradyarrhythmias, severe peripheral vascular disease, or decompensated heart failure. The contraindications are real and should be discussed with the prescribing clinician.
Hypotension and bradycardia can occur, particularly at higher doses or in patients who are already at the low end of normal for blood pressure or heart rate.
For generalized anxiety treated with an SSRI, beta-blockers occasionally help with residual somatic symptoms but shouldn't be the primary intervention.
For panic disorder, beta-blockers don't address the underlying interoceptive sensitization that drives the condition. CBT with interoceptive exposure and SSRIs are the treatments with the strongest evidence for panic disorder.
The situations they fit
The most established use: performance anxiety. Public speaking, auditions, exam-taking, athletic performance, and similar discrete events where physical symptoms are the main concern. A typical regimen is propranolol 10 to 40 mg taken thirty to sixty minutes before the event. The effect lasts three to four hours. Many patients use this only on the rare occasions when needed, perhaps a few times per year.
A secondary use: the somatic component of generalized anxiety disorder in patients who tolerate SSRIs poorly. Propranolol can be added at low daily doses to reduce the body's reactivity while the SSRI works on the underlying anxiety.
A specific note for medical students, professional musicians, attorneys, and others in performance-heavy careers: propranolol used a few times per year for high-stakes events is generally well-tolerated and clinically reasonable. The medication isn't a controlled substance, doesn't produce dependence, and is one of the more commonly used off-label anxiety medications in these fields.
Side effects and cautions
Beta-blockers are generally well-tolerated at the low doses used for anxiety. Common side effects: mild fatigue, cold hands, vivid dreams. Less common but notable: bradycardia (slow heart rate), hypotension (low blood pressure), reduced exercise tolerance.
Specific cautions.
Asthma. Non-selective beta-blockers can trigger bronchospasm in asthmatics. Selective beta-blockers (atenolol, metoprolol) are alternatives, though they have less data for anxiety specifically.
Diabetes. Beta-blockers can mask the early signs of hypoglycemia (the rapid heartbeat that would normally warn the patient). Patients with insulin-dependent diabetes should discuss this with their clinician.
Cardiac conditions. Most patients with cardiac disease are already on beta-blockers, but the dosing for anxiety is different from cardiac dosing and should be coordinated.
Pregnancy. Beta-blockers cross the placenta and can affect fetal heart rate. Use in pregnancy requires specific discussion with an obstetrician.
Comparison with other PRN anxiety options
For a discrete event, propranolol targets the physical symptoms with minimal sedation and no dependence potential. lorazepam targets all symptoms including the cognitive ones, but at the cost of significant sedation, slowed thinking, and dependence risk if used regularly. hydroxyzine sits in between, moderately sedating, not habit-forming, with a slightly slower onset. For pure performance anxiety where mental clarity matters, propranolol usually wins.
External references
The American Heart Association overview of beta-blockers covers their cardiac mechanism. For psychiatric use, the APA practice guidelines discuss propranolol's role in performance anxiety subtypes.
Related: Social anxiety disorder · How CBT and SSRIs actually work for anxiety · Benzodiazepines for anxiety · Hydroxyzine for anxiety